INNOVIVA, INC. Equity Securities, FV-NI, Realized Gain (Loss)
INNOVIVA, INC. (INVA) reported Equity Securities, FV-NI, Realized Gain (Loss) of $7.70 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2023-11-01
- INNOVIVA, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2022-09-30 was $0.00.
- INNOVIVA, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2022-06-30 was -$100.00K.
- INNOVIVA, INC. equity securities, fv-ni, realized gain (loss) for the quarter ending 2022-03-31 was $7.80M.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$100.00K derived: sum of 2 quarters · filed 2022-11-09 | $7.70M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $7.70M 10-Q · filed 2022-07-27 | ||
| 2022-03-31 | $7.80M 10-Q · filed 2023-11-01 | |||
| 2022-02-17 | $7.70M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |